Diabetes Medication Choice

Not Applicable

Completed

• Conditions: Type 2 Diabetes
• Interventions: Behavioral: Usual Care; Behavioral: Diabetes Medication Choice decision aid

• Registration Number: NCT00388050
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07
• Study First Submitted: 2006-10-12
• Study First Submitted QC: 2006-10-12
• Study First Posted: 2006-10-13
• Primary Completion: 2008-10
• Study Completion: 2008-10
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-27
• Last Update Posted: 2015-04-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 85

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Usual Care	Usual Care	Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.
Diabetes Medication Choice decision aid	Diabetes Medication Choice decision aid	Patients in this arm will discuss diabetes medication for glucose control with the help of a decision aid that covers five commonly prescribed anti-hyperglycemic medications.

Primary Outcome Measures

Name	Time	Method
Understanding	Directly proceeding the clinical encounter
Decisional Conflict	Directly proceeding the clinical visit
Treatment Action, adherence	Directly proceeding the clinical encounter, 6 months after the clinical encounter

Secondary Outcome Measures

Name	Time	Method
Trust	Directly proceeding the clinical visit
Acceptability	Directly proceeding the clinical encounter

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States